LSE : GDR.L

Genedrive Plc

$1.05 GBp

$0 (0.0%)

Volume
116.43K
Average Volume
6.88M
Market Capitalization
$6.16M
P/E Ratio
-0.96
Dividend Yield
0.00%
Price Target
Year High
$1.50
Year Low
$0.19
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.99
Company Overview

LSE

Gino Miele

Medical - Diagnostics & Research

Healthcare

GDR.L

43

GB

GBp

https://www.genedriveplc.com

44 16 1989 0245

G3791Q102

N/A

Liquidity Metrics

-1.20

0.99

0.78

0.23

0.00

Sales & Valuation

$764K

5.78

-21.41

-1.58

0.00

Profitability

-$0.0093

-$5.23M

-500.75%

-516.68%

-1044.57%

-304.62%

P/E Metrics

-0.96

-0.01

-0.01

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Financial Health Scores

-76.74

3/9

-$24000

$1.75M

$2.17M

-$13.51M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Russell John Shaw Chief Financial Officer, Secretary & Director
Gino Miele Chief Executive Officer, Chief Scientific Officer & Executive Director
Poll Results

No votes yet today — be the first to share your view!

About Genedrive Plc (LSE:GDR.L) Stock

Genedrive Plc, a molecular diagnostics firm established in Manchester, UK, in 2000 (and known as Epistem Holdings Plc until its name change in July 2016), focuses on developing and commercializing innovative point-of-care diagnostic platforms. These solutions cater to a range of applications, including the identification of infectious diseases, genetic profiling, and pathogen detection. At the core of their offerings is the proprietary Genedrive system, a compact polymerase chain reaction (PCR) technology. This advanced platform enables the rapid amplification and detection of nucleic acids from diverse biological samples, such as plasma, sputum, and buccal swabs. The Genedrive platform features several key diagnostic products: the Genedrive HCV ID Kit for qualitative Hepatitis C virus det ... ection; the Genedrive BioPlex, designed for the quick identification of military biothreats from pathogens; and the Genedrive MT-RNR1-ID Kit, a rapid genetic test vital for emergency neonatal care. Complementing these is the Genedrive Connect app, an Android-based mobile application that streamlines data management and facilitates results transmission. Genedrive Plc serves the biotechnology and pharmaceutical sectors globally, with its reach extending throughout the United Kingdom, Europe, the United States, and other international regions. The company has also partnered with Beckman Coulter Life Sciences to automate laboratory PCR testing procedures for COVID-19.

Frequently Asked Questions

What is the current Genedrive Plc (GDR.L) stock price?

Genedrive Plc(LSE:GDR.L) stock price is $1.05 in the last trading session. During the trading session, GDR.L stock reached the peak price of $1.5 while $0.19 was the lowest point it dropped to. The percentage change in GDR.L stock occurred in the recent session was 0.0% while the dollar amount for the price change in GDR.L stock was $0.

GDR.L's industry and sector of operation?

The LSE listed GDR.L is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of GDR.L?

Russell John Shaw | Chief Financial Officer, Secretary & Director
Gino Miele | Chief Executive Officer, Chief Scientific Officer & Executive Director
|
|
|

How many employees does GDR.L have?

Number of GDR.L employees currently stands at 43. GDR.L operates from The CTF Building, Manchester, GM M13 9XX, GB.

Link for GDR.L official website?

Official Website of GDR.L is: https://www.genedriveplc.com

How do I contact GDR.L?

GDR.L could be contacted at phone #44 16 1989 0245 and can also be accessed through its website. GDR.L operates from The CTF Building, Manchester, GM M13 9XX, GB.

How many shares of GDR.L are traded daily?

The average number of GDR.L shares traded daily for last 3 months was 6.88M.

What is the market cap of GDR.L currently?

The market value of GDR.L currently stands at $6.16M with its latest stock price at $1.05